UNII 7YIN7J07X4

TREHALOSE DIHYDRATE

UNII Information

Unique Ingredient Identifier: 7YIN7J07X4
The Unique Ingredient Identifier (UNII) is a unique alphanumeric code assigned to a specific substance or ingredient by the FDA (Food and Drug Administration). UNII codes are non-proprietary, free, unique, unambiguous and nonsemantic. Each UNII code consists of 10 characters with both letters and numbers. The first two characters represent the source of the substance while the remaining eight characters represent the specific substance. UNII codes are primarily used to identify and track substances in several drug databases and regulatory documents related to drugs, biologics, and medical devices.
Formula: C12H22O11.2H2O
Molecular Formula, total atoms represented as a molecular structure in a UNII description.
Preferred Substance Name: TREHALOSE DIHYDRATE
The Preferred Substance Name (PSN) is the official or preferred name of a substance or ingredient. The preferred name provides a standardized and consistent name for each substance is used in the UNII code system. The preferred name may differ from other names also commonly used to refer the same substance. The PSN is usually the name used by regulatory agencies like the FDA.
InChIKey: DPVHGFAJLZWDOC-PVXXTIHASA-N
The InChIKey to a unique identifier for a specific substance or ingredient that is based on its molecular structure. InChIKey stands for International Chemical Identifier Key and is a fixed-length string created from the IUPAC International Chemical Identifier (InChI). The InChIKey is useful in drug development and chemical analysis, where the molecular structure of a substance is an important factor in determining its properties and effects.
SMILES: [C@H]1([C@H](O[C@@H]([C@@H]([C@H]1O)O)O[C@@]2([C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)[H])CO)O.O.O
The Simplified Molecular Input Line Entry System or SMILES is a format used to represent and describe the molecular structure of a substance or ingredient. SMILES uses a series of alphanumeric characters to represent the atoms and bonds in a molecule in conjunction with other symbols and operators to indicate the arrangement and connectivity of the atoms.
Registry Number: 6138-23-4
The Registry Number is the unique numerical identifiers assigned to a substance or ingredient by the Chemical Abstracts Service (CAS). The CAS registry number is a used and recognized standard identifier by many industries and regulatory agencies. The Registry Number facilitates cross-referencing substances between different databases that may use different naming conventions or identifiers.
NCI Thesaurus Concept Code: C87706
The NCI Thesaurus give reference terminology for many systems. The code includes vocabulary for clinical care, translational research, basic research, public information and administrative activities.
UNII to RxNorm Crosswalk: 1311372 (RXCUI)
The RxNorm Ingredient Concept Code is the numeric code assigned to a specific substance or ingredient by the National Library of Medicine's RxNorm system. By including the RxNorm code in the UNII code system it is possible to crossover UNII codes to RxNom.
PubChem Compound ID: 181978
The PubChem Compound ID is a unique identifier for a specific substance or ingredient in the PubChem database which is the largest collection of freely accessible chemical information by the National Center for Biotechnology Information. The PubChem database is a resource for drug discovery, development, chemical research, and other applications.
Ingredient Type: INGREDIENT SUBSTANCE
Substance Type: 1f9b8861-9f3e-4127-90f8-57a2b284b772
The International Organization for Standardization - ISO 11238 substance type is used as a data element in the UNII code system to provide additional information about the type of substance being identified.

UNII Synonyms and Mappings

The following synonyms and mappings provide alternative ways to refer to the same substance or ingredient. Synonyms may include different names or spellings, alternate chemical names, trade names, or other common names.

  • .ALPHA., .ALPHA.-TREHALOSE DIHYDRATE - Common Name
  • .ALPHA.-D-GLUCOPYRANOSYL-.ALPHA.-D-GLUCOPYRANOSIDE DIHYDRATE - Common Name
  • D-TREHALOSE DIHYDRATE - Common Name
  • FEMA NO. 4600 - Code
  • MYCOSE DIHYDRATE - Common Name
  • TREHALOSE DIHYDRATE - Common Name
  • TREHALOSE DIHYDRATE [EP MONOGRAPH] - Common Name
  • TREHALOSE DIHYDRATE [MI] - Common Name
  • TREHALOSE DIHYDRATE [WHO-DD] - Common Name

UNII Resources

Common Chemistry
CAS Common Chemistry is an open community resource of the American Chemical Society for accessing chemical information. The chemical information in the CAS database is curated by expert scientists and includes information of common and frequently regulated chemicals and information applicable to high school and undergraduate chemistry classes.
Inxight Drugs
The National Center for Advancing Translational Sciences (NCATS) Inxight Drugs database has a comprehensive drug development information. The NCATS Inxight Drugs includes manually curated data provided by private companies and FDA. The database has marketing and regulatory status information, rigorous drug ingredient definitions, biological activity, clinical use, etc.
DailyMed Regulated Products
The National Library of Medicine DailyMed is a searchable database that includes the most recent product labeling information submitted to the FDA by private companies.
NCATS GSRS Full Record
The Global Substance Registration System (GSRS) was designed to facilitate global monitoring of human and animal medicinal, food, tobacco, and cosmetic products. GSRS includes unique substance identifiers consistent with the ISO 11238 standard.
NCI Thesaurus
NCI Thesaurus (NCIt) by the National Cancer Institute provides reference terminology for clinical care, translational and basic research, and public information and administrative activities.
PubChem
The PubChem database by the National Library of Medicine includes the chemical structures of small organic molecules and information on their biological activities.

UNII Crossover to NDC Codes

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0639Proprietary Name: Cosentyx SecukinumabInjectionSubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0078-1056Proprietary Name: Cosentyx SecukinumabInjectionSubcutaneousNovartis Pharmaceuticals CorporationACTIVE
0173-0896Proprietary Name: Blenrep Glaxosmithkline Llc
0310-1730Proprietary Name: Fasenra BenralizumabInjection, SolutionSubcutaneousAstrazeneca Pharmaceuticals LpACTIVE
0310-1830Proprietary Name: Fasenra BenralizumabInjection, SolutionSubcutaneousAstrazeneca Pharmaceuticals LpACTIVE
0310-3040Proprietary Name: Saphnelo Anifrolumab-fniaInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
0310-4500Proprietary Name: Imfinzi DurvalumabInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
0310-4611Proprietary Name: Imfinzi DurvalumabInjection, SolutionIntravenousAstrazeneca Pharmaceuticals LpACTIVE
0944-4622Proprietary Name: Adynovate Antihemophilic Factor (recombinant) PegylatedKitTakeda Pharmaceuticals Amercia, Inc.ACTIVE
0944-4623Proprietary Name: Adynovate Antihemophilic Factor (recombinant) PegylatedKitTakeda Pharmaceuticals Amercia, Inc.ACTIVE
0944-4624Proprietary Name: Adynovate Antihemophilic Factor (recombinant) PegylatedKitTakeda Pharmaceuticals Amercia, Inc.ACTIVE
0944-4625Proprietary Name: Adynovate Antihemophilic Factor (recombinant) PegylatedKitTakeda Pharmaceuticals Amercia, Inc.ACTIVE
0944-4626Proprietary Name: Adynovate Antihemophilic Factor (recombinant) PegylatedKitTakeda Pharmaceuticals Amercia, Inc.ACTIVE
0944-4627Proprietary Name: Adynovate Antihemophilic Factor (recombinant) PegylatedKitTakeda Pharmaceuticals Amercia, Inc.ACTIVE
0944-4628Proprietary Name: Adynovate Antihemophilic Factor (recombinant) PegylatedKitTakeda Pharmaceuticals Amercia, Inc.ACTIVE
0944-7551Proprietary Name: Vonvendi Von Willebrand Factor (recombinant)KitTakeda Pharmaceuticals America, Inc.ACTIVE
0944-7553Proprietary Name: Vonvendi Von Willebrand Factor (recombinant)KitTakeda Pharmaceuticals America, Inc.ACTIVE
49281-605Proprietary Name: Dengvaxia Dengue Tetravalent Vaccine, LiveKitSanofi Pasteur Inc.ACTIVE
50242-060Proprietary Name: Avastin BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-061Proprietary Name: Avastin BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-070Proprietary Name: Gazyva ObinutuzumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-077Proprietary Name: Herceptin Hylecta Trastuzumab And Hyaluronidase-oyskInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-077Proprietary Name: Herceptin Hylecta Genentech, Inc.
50242-080Proprietary Name: Lucentis RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-082Proprietary Name: Lucentis RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-108Proprietary Name: Rituxan Hycela Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-109Proprietary Name: Rituxan Hycela Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-132Proprietary Name: Herceptin TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousGenentech, Inc.ACTIVE
50242-150Proprietary Name: Ocrevus OcrelizumabInjectionIntravenousGenentech, Inc.ACTIVE
50242-245Proprietary Name: Phesgo Pertuzumab, Trastuzumab, And Hyaluronidase-zzxfInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-260Proprietary Name: Phesgo Pertuzumab, Trastuzumab, And Hyaluronidase-zzxfInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-554Proprietary Name: Ocrevus Zunovo Ocrelizumab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50881-013Proprietary Name: Monjuvi Tafasitamab-cxixInjection, Powder, Lyophilized, For SolutionIntravenousIncyte CorporationACTIVE
51144-020Proprietary Name: Padcev EJFVEnfortumab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.ACTIVE
51144-030Proprietary Name: Padcev EJFVEnfortumab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.ACTIVE
51144-050Proprietary Name: Adcetris Brentuximab VedotinInjection, Powder, Lyophilized, For SolutionIntravenousSeagen Inc.ACTIVE
52658-7777Proprietary Name: Lymphir Denileukin Diftitox-cxdlInjection, Powder, Lyophilized, For SolutionIntravenousCitius Pharmaceuticals, Inc.ACTIVE
55513-056Proprietary Name: Pavblu Aflibercept-ayyhInjection, SolutionIntravitrealAmgen, IncACTIVE
55513-065Proprietary Name: Pavblu Aflibercept-ayyhInjection, SolutionIntravitrealAmgen, IncACTIVE
55513-132Proprietary Name: Kanjinti Trastuzumab-annsInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncACTIVE
55513-160Proprietary Name: Blincyto BlinatumomabKitAmgen IncACTIVE
55513-206Proprietary Name: Mvasi Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
55513-207Proprietary Name: Mvasi Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
58160-848Proprietary Name: Arexvy Respiratory Syncytial Virus Vaccine Recombinant, AdjuvantedKitGlaxosmithkline Biologicals SaACTIVE
59137-282Proprietary Name: Ixinity Coagulation Factor Ix (recombinant)KitMedexus Pharma, Inc.ACTIVE
59137-283Proprietary Name: Ixinity Coagulation Factor Ix (recombinant)KitMedexus Pharma, Inc.ACTIVE
59137-284Proprietary Name: Ixinity Coagulation Factor Ix (recombinant)KitMedexus Pharma, Inc.ACTIVE
59137-287Proprietary Name: Ixinity Coagulation Factor Ix (recombinant)KitMedexus Pharma, Inc.ACTIVE
59137-288Proprietary Name: Ixinity Coagulation Factor Ix (recombinant)KitMedexus Pharma, Inc.ACTIVE
59137-289Proprietary Name: Ixinity Coagulation Factor Ix (recombinant)KitMedexus Pharma, Inc.ACTIVE
63459-305Proprietary Name: Herzuma TrastuzumabKitCephalon, Inc.ACTIVE
64406-019Proprietary Name: Byooviz Ranibizumab-nunaInjection, SolutionIntravitrealBiogen Inc.ACTIVE
65219-554Proprietary Name: Idacio Adalimumab-aacfKitSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-556Proprietary Name: Idacio Adalimumab-aacfKitSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-558Proprietary Name: Idacio Adalimumab-aacfKitFresenius Kabi Usa, LlcACTIVE
65219-612Proprietary Name: Adalimumab-aacf AdalimumabKitSubcutaneousFresenius Kabi Usa, LlcACTIVE
65857-425Proprietary Name: Kit For The Preparation Of Lymphoseek (technetium Tc 99m Tilmanocept) TilmanoceptKitCardinal Health 414, LlcACTIVE
65857-450Proprietary Name: Kit For The Preparation Of Lymphoseek (technetium Tc 99m Tilmanocept) TilmanoceptKitCardinal Health 414, LlcACTIVE
68727-900Proprietary Name: Rylaze Asparaginase Erwinia Chrysanthemi (recombinant)-rywnInjectionIntramuscularJazz Pharmaceuticals, Inc.ACTIVE
69448-015Proprietary Name: Hercessi Trastuzumab-strfInjection, Powder, Lyophilized, For SolutionIntravenousAccord Biopharma Inc.ACTIVE
69448-016Proprietary Name: Hercessi Trastuzumab-strfInjection, Powder, Lyophilized, For SolutionIntravenousAccord Biopharma Inc.ACTIVE
70121-1754Proprietary Name: Alymsys Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
70121-1755Proprietary Name: Alymsys Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
71202-010Proprietary Name: Epysqli Samsung Bioepis Co., Ltd.
71837-1000Proprietary Name: Bizengri ZenocutuzumabInjectionIntravenousPartner Therapeutics, Inc.ACTIVE
71981-001Proprietary Name: Oxervate Cenegermin-bkbjKitDomp� Farmaceutici S.p.a.ACTIVE
71981-020Proprietary Name: Oxervate Cenegermin-bkbjSolution/ DropsOphthalmicDomp� Farmaceutici S.p.a.ACTIVE
72247-101Proprietary Name: Curodont Repair Fluoride Plus Credentis AgINACTIVATED
72247-106Proprietary Name: Curodont Repair Fluoride Plus Credentis Ag
72247-108Proprietary Name: Curodont Repair Fluoride Plus Sodium FluorideSpongeOralCredentis AgACTIVE
72606-011Proprietary Name: Vegzelma Bevacizumab-adcdInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-012Proprietary Name: Vegzelma Bevacizumab-adcdInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72677-551Proprietary Name: Uplizna InebilizumabInjectionIntravenousViela Bio, Inc.ACTIVE
72960-112Proprietary Name: Daxxify Botulinum Toxin Type AInjection, Powder, Lyophilized, For SolutionIntramuscularRevance Therapeutics, Inc.ACTIVE
73535-208Proprietary Name: Monjuvi Tafasitamab-cxixInjection, Powder, Lyophilized, For SolutionIntravenousIncyte CorporationACTIVE
73606-020Proprietary Name: Syfovre PegcetacoplanInjection, SolutionIntravitrealApellis Pharmaceuticals, Inc.ACTIVE
75987-130Proprietary Name: Tepezza TeprotumumabInjection, Powder, Lyophilized, For SolutionIntravenousHorizon Therapeutics Usa, Inc.ACTIVE
75987-150Proprietary Name: Uplizna InebilizumabInjectionIntravenousHorizon Therapeutics Usa, Inc.ACTIVE
78206-147Proprietary Name: Ontruzant TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousOrganon LlcACTIVE
78206-148Proprietary Name: Ontruzant OntruzantKitIntravenousOrganon LlcACTIVE
82143-001Proprietary Name: Avzivi tnjnBevacizumabInjection, SolutionIntravenousBio-thera Solutions, Ltd.ACTIVE
82143-002Proprietary Name: Avzivi Bevacizumab-tnjnInjection, SolutionIntravenousBio-thera Solutions, Ltd.ACTIVE
83077-100Proprietary Name: Bizengri ZenocutuzumabInjectionIntravenousMerus Us, Inc.ACTIVE
83885-002Proprietary Name: Acne Scar Repair Cream Guangzhou Guocui Biological Technology Co., Ltd
83885-007Proprietary Name: Acne Scar Repair Cream Guangzhou Guocui Biological Technology Co., Ltd
84345-443Proprietary Name: Medical Recombinant Type Iii Humanized Collagen Repair Patch Medical Recombinant Type Iii Humanized Collagen Repair PatchPatchTopicalHunan Yinhuatang Pharmaceutical Technology Co., LtdACTIVE